METABOLISM OF DAPSONE TO ITS HYDROXYLAMINE BY CYP2E1 IN-VITRO AND IN-VIVO

Dapsone toxicity is putatively initiated by formation of a hydroxylami ne metabolite by cytochromes P450. In human liver microsomes, the kine tics of P450-catalyzed N-oxidation of dapsone were biphasic, with the Michaelis-Menten constants of 0.14 +/- 0.05 and 0.004 +/- 0.003 mmol/L and the respective maximum velocities of 1.3 +/- 0.1 and 0.13 +/- 0.0 4 nmol/mg protein/min (mean +/- SEM). Troleandomycin (40 mu mol/L) inh ibited hydroxylamine formation at 100 mu mol/L dapsone by 50%; diethyl dithiocarbamate (150 mu mol/L) and tolbutamide (400 mu mol/L) inhibite d at 5 mu mol/L dapsone by 50% and 20%, respectively, suggesting that the low-affinity isozyme is CYP3A4 and the high-affinity isozymes are 2E1 and 2C. Disulfiram, 500 mg, 18 hours before a 100 mg oral dose of dapsone in healthy volunteers, diminished area under the hydroxylamine plasma concentration-time curve by 65%, apparent formation clearance of the hydroxylamine by 71%, and clearance of dapsone by 26%. Disulfir am produced a 78% lower concentration of methemoglobin 8 hours after d apsone.